API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/oncorenas-first-patient-treated-with-onc175-orellanine-in-clinical-phase-iii-trial-in-patients-with-metastatic-renal-cancer-and-dialysis-at-karolinska-university-hospital-in-stockholm-sweden-301916760.html
https://www.biospace.com/article/releases/oncorena-initiates-the-phase-i-ii-clinical-trial-with-orellanine-in-advanced-kidney-cancer-patients-at-karolinska-university-hospital-in-sweden/
https://www.prnewswire.com/news-releases/oncorena-secures-financing-of-the-companys-continued-development-of-orellanine-a-potential-breakthrough-therapy-for-advanced-renal-cancer-301450285.html